glp-1 injection pen Decoding Weight Loss Medications 4 Ways Pharmacists Can Help

If obesity is treated as a chronic biological condition rather than a short-term problem, GLP-1s begin to look less like a treatment and more like a sustained system patients may not easily exit

There also have been sporadic warning letters (like this one from December 2025) citing the unlawful distribution of unapproved GLP-1 agonists, such as retatrutide, to compounders

All observations (#1, #102 and #3) are therefore already publicly accessible on MAST 68,159

Retrieved from MercyOne.org

Clin Med Lond Engl 18:245250 Shaotong M et al (2022) The protective effects of sulforaphane on high-fat diet-induced metabolic associated fatty liver disease in mice via mediating the FXR/LXR pathway